OCA 5MG IR +BZF 400 MG SR
977-311
Phase 3 small_molecule active
Quick answer
OCA 5MG IR +BZF 400 MG SR for Primary Biliary Cholangitis (PBC) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Primary Biliary Cholangitis (PBC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active